胰腺腺状癌患者的新辅助疗法的作用:来自国家癌症数据库的结果

相关实验视频

Updated: May 2, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

Amanda K Walsh¹, Diamantis I Tsilimigras¹, Alex B Blair¹

¹Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, 43210, USA.

Journal of gastrointestinal cancer

|July 2, 2025

概括

手术前的新辅助疗法 (NT) 改善了胰腺腺素状癌 (PASC) 患者的整体存活率. 这种方法显示出比这种罕见的癌症的手术更好的结果.

科学领域:

在瘤学瘤学.
手术瘤学手术瘤学
胃肠病学胃肠病学

背景情况:

胰腺状腺癌 (PASC) 是一种罕见的,激进的癌症.
它的管理通常反映胰腺管道腺癌 (PDAC).
新辅助疗法 (NT) 对PDAC很常见,但其对PASC的益处尚不清楚.

研究的目的:

调查新辅助疗法 (NT) 对局部胰腺状癌 (PASC) 患者的整体存活期 (OS) 的影响.
为了比较PASC患者在手术前接受NT的结果与那些首先接受手术 (SF) 的人.

主要方法:

对国家癌症数据库 (NCDB) 对I-III阶段PASC患者 (2006-2020) 的分析.
在手术前接受NT和首先接受手术 (SF) 的患者之间的整体存活 (OS) 的比较.
多变量考克斯回归分析确定了与改善或降低OS相关的因素.

主要成果:

在1191名PASC患者中,17.5%的患者在手术前接受了NT.
与SF相比,NT与显著改善的OS相关 (中位数为20.7个月与15.9个月).
改善OS的独立因素包括NT,学术治疗设施和辅助疗法.

结论:

切除前的新辅助疗法 (NT) 与局部胰腺腺癌 (PASC) 的更好的整体存活率 (OS) 有关.
需要进一步的研究来确定最佳的NT疗法,包括手术前辐射的作用.
提高PASC患者的治疗反应和长期结果是关键目标.

关键词:

国家癌症数据库.新辅助疗法是一种新辅助疗法.胰腺腺状腺癌瘤胰腺癌是一种胰腺癌.首先是外科手术.

更多相关视频

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.